113 related articles for article (PubMed ID: 17384203)
1. The time to move cytochrome p450 induction into mainstream pharmacology is long overdue.
Smith DA; Dickins M; Fahmi OA; Iwasaki K; Lee C; Obach RS; Padbury G; De Morais SM; Ripp SL; Stevens J; Voorman R; Youdim K
Drug Metab Dispos; 2007 Apr; 35(4):697-8. PubMed ID: 17384203
[No Abstract] [Full Text] [Related]
2. Development of three parallel cytochrome P450 enzyme affinity detection systems coupled on-line to gradient high-performance liquid chromatography.
Kool J; van Liempd SM; van Rossum H; van Elswijk DA; Irth H; Commandeur JN; Vermeulen NP
Drug Metab Dispos; 2007 Apr; 35(4):640-8. PubMed ID: 17251308
[TBL] [Abstract][Full Text] [Related]
3. [Use of cytochrome P-450 induction as 1 of the new principles of therapy in organophosphate insecticide poisonings].
Kagan IuS; Kokshareva NV; Ovsiannikova LM; Samusenko II
Vestn Akad Med Nauk SSSR; 1980; (8):55-8. PubMed ID: 7415524
[No Abstract] [Full Text] [Related]
4. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
Hengstler JG; Bolt HM
Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
[No Abstract] [Full Text] [Related]
5. Inhibition and induction of human cytochrome P450 enzymes: current status.
Pelkonen O; Turpeinen M; Hakkola J; Honkakoski P; Hukkanen J; Raunio H
Arch Toxicol; 2008 Oct; 82(10):667-715. PubMed ID: 18618097
[TBL] [Abstract][Full Text] [Related]
6. A new and simple method to test drug interactions with metabolic enzymes of rats in vivo.
Hanauer G
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):557-62. PubMed ID: 2093135
[TBL] [Abstract][Full Text] [Related]
7. Induction of cytochrome P450 enzymes: a view on human in vivo findings.
Hukkanen J
Expert Rev Clin Pharmacol; 2012 Sep; 5(5):569-85. PubMed ID: 23121279
[TBL] [Abstract][Full Text] [Related]
8. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective.
Chu V; Einolf HJ; Evers R; Kumar G; Moore D; Ripp S; Silva J; Sinha V; Sinz M; Skerjanec A
Drug Metab Dispos; 2009 Jul; 37(7):1339-54. PubMed ID: 19389860
[TBL] [Abstract][Full Text] [Related]
10. Prediction of CYP-mediated drug interactions in vivo using in vitro data.
Foti RS; Wahlstrom JL
IDrugs; 2008 Dec; 11(12):900-5. PubMed ID: 19051152
[TBL] [Abstract][Full Text] [Related]
11. Effects of mammalian CYP3A inducers on CYP3A-related enzyme activities in grass carp (Ctenopharyngodon idellus): Possible implications for the establishment of a fish CYP3A induction model.
Li D; Yang XL; Zhang SJ; Lin M; Yu WJ; Hu K
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Jan; 147(1):17-29. PubMed ID: 17826359
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome-P450 induction and antineoplastic action of fotemustine in mice.
Isa M; Cumps J; Poupaert JH; Atassi G
J Pharm Belg; 1996; 51(4):192-4. PubMed ID: 8965249
[No Abstract] [Full Text] [Related]
13. Cytochrome P450 enzymes.
Donaldson D
J R Soc Promot Health; 2000 Sep; 120(3):150-1. PubMed ID: 11077800
[No Abstract] [Full Text] [Related]
14. Non-coplanar 2,2',3,3',4,4',5,5',6,6'-decachlorobiphenyl (PCB 209) did not induce cytochrome P450 enzyme activities in primary cultured rat hepatocytes, was not genotoxic, and did not exhibit endocrine-modulating activities.
Han X; O'Connor JC; Donner EM; Nabb DL; Mingoia RT; Snajdr SI; Clarke JJ; Kaplan AM
Toxicology; 2009 Jan; 255(3):177-86. PubMed ID: 19022331
[TBL] [Abstract][Full Text] [Related]
15. Effect of Pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes.
Price RJ; Giddings AM; Scott MP; Walters DG; Capen CC; Osimitz TG; Lake BG
Toxicology; 2008 Jan; 243(1-2):84-95. PubMed ID: 18022748
[TBL] [Abstract][Full Text] [Related]
16. Rifabutin autoinduction is caused by involvement of cytochrome P450 and cholinesterase.
Zhaoxu L; Jingcheng T; Jinnan Z
Pharmazie; 2008 Feb; 63(2):156-9. PubMed ID: 18380404
[TBL] [Abstract][Full Text] [Related]
17. Experimental models for evaluating enzyme induction potential of new drug candidates in animals and humans and a strategy for their use.
Thompson TN
Adv Pharmacol; 1997; 43():205-29. PubMed ID: 9342178
[TBL] [Abstract][Full Text] [Related]
18. Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations.
Hewitt NJ; Lecluyse EL; Ferguson SS
Xenobiotica; 2007; 37(10-11):1196-224. PubMed ID: 17968743
[TBL] [Abstract][Full Text] [Related]
19. [The sequelae of cytochrome P-450 induction].
Lukienko PI; Zavodnik LB; Bushma MI
Eksp Klin Farmakol; 1995; 58(1):68-73. PubMed ID: 7787705
[No Abstract] [Full Text] [Related]
20. Induction of drug metabolism: species differences and toxicological relevance.
Graham MJ; Lake BG
Toxicology; 2008 Dec; 254(3):184-91. PubMed ID: 18824059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
